Advances in Cancer Immunotherapy™ Webinar

When:  Aug 12, 2017 from 08:00 to 14:00 (CT)

Webinar Program Description
sitc_log_color.png
Specifically designed for attendees who are unable to attend an Advances in Cancer Immunotherapy™ (ACI) program in person, the Advances in Cancer Immunotherapy™ Webinar offers attendees the opportunity to participate in the program online. Webinar attendees receive the educational benefits of attending an ACI program, including the ability to participate in Audience Response System (ARS) questions during the program and ask questions of program faculty during Q&A sessions.

After registering for the webinar, webinar attendees will receive additional instructions via email with a link to the webinar and a webinar access code.

Share this event in your network


Organizers:

Christian Capitini, MD – University of Wisconsin Carbone Cancer Center
Sigrun Hallmeyer, MD – Advocate Medical Group
Anne Wolvin, RN – University of Wisconsin Carbone Cancer Center

Program Purpose

Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are introductory, CME-, CPE- and CNE-certified programs. Presented by leading and local authorities in tumor immunology and cancer immunotherapy, these six-hour programs will facilitate understanding of:

  • The rationale for common approaches to immunotherapy
  • The clinical applications of immunotherapy for disease states with FDA-approved treatments (melanoma, and lung, genitourinary, hematologic, and head and neck cancers)
  • Operational and reimbursement barriers to implementing immunotherapy in a community setting and strategies to overcome them
  • The identification and management of immune-related adverse events from the nursing and prescriber perspective in the clinic and emergency settings

Webinar attendees will also have an opportunity for connecting with regional experts in the immunotherapy field through two Immuno-Oncology (IO) Cup o' Joe webinars after the program and indefinitely through a dedicated online community forum. These connections will serve as ongoing resources while clinical oncologists and other healthcare providers incorporate immunotherapy into practice. 

For more information, including program objectives, click here.

This program is presented in collaboration with the American Academy of Emergency Medicine (AAEM) and the Association of Community Cancer Centers (ACCC).      

                    

 

 


Program Registration 

SITC members are eligible for discounted registration rates. To receive discounted member rates, your membership dues must be current through 2017.

Click here to learn more about the registration rates for members and non-members for this program.

Program Agenda

Preprogram Course: Introduction to Immunology

Participation in this online preprogram course is strongly recommended as it contains information that will not be covered at the onlin program on August 12. This interactive course provides foundational knowledge that is necessary for understanding cancer immunotherapy content that will be discussed at the in-person program. Please click HERE to access the course.


August 12 Program

Presentations include time for Audience Response System (ARS)-assisted audience
interaction as well as general question and answer time.

7 – 8 a.m.

Check-in, Onsite Registration and Networking

Part A: Introduction to Incorporating Immunotherapy Into Clinical Practice

Session I: From Basic Principles to Clinical Applications of Cancer Immunotherapy

8 – 8:05 a.m.

Welcome, Introduction, and Pretest Questions by the Society for Immunotherapy of Cancer

8:05 – 8:35 a.m.

Basic Principles of Cancer Immunotherapy
Monica Thakar, MD – Medical College of Wisconsin

8:35 – 8:55 a.m.

Immunotherapy for the Treatment of Melanoma
Mark R. Albertini, MD – University of Wisconsin Carbone Cancer Center

8:55 – 9:15 a.m.

Immunotherapy for the Treatment of Lung Cancer
Ticiana A. Leal, MD – University of Wisconsin Carbone Cancer Center

9:15 – 9:35 a.m.

Immunotherapy for the Treatment of Genitourinary Cancers
Douglas G. McNeel, MD, PhD – University of Wisconsin Carbone Cancer Center

9:35 – 9:55 a.m

Immunotherapy for the Treatment of Hematologic Malignancies
Timothy S. Fenske, MD – Medical College of Wisconsin

9:55 – 10:15 a.m

Immunotherapy for the Treatment of Head and Neck Cancers
Robert F. Taylor, MD – Aurora Health Care

10:15 – 10:25 a.m

 Break

Session II: Overcoming Barriers to Incorporating Immunotherapy Into Community Practice

10:25 – 10:30 a.m.

Information About the Society for Immunotherapy of Cancer Resources

10:30 – 11 a.m.

Effective Practices for Incorporating Immunotherapy Into Hospital Operations
Sigrun Hallmeyer, MD – Advocate Medical Group

11 – 11:30 a.m.

Coverage and Reimbursement Challenges and Strategies
Sigrun Hallmeyer, MD – Advocate Medical Group

11:30 – 11:35 a.m.

Take-Home Points for Part A

11:35 a.m. – noon

Lunch

Part B: Immune-Related Adverse Event (irAE) Management

noon – 12:20 p.m.

Mechanisms of Immune-Related Adverse Events
Bryon D. Johnson, PhD – Medical College of Wisconsin

12:20 – 12:50 p.m.

Nursing Perspective on irAEs: Patient Education, Monitoring and Management
Anne Wolvin, RN – University of Wisconsin Carbone Cancer Center

12:50 – 1:20 p.m.

Management and Mitigation of irAEs for Immunotherapy Prescribers
Christian Capitini, MD – University of Wisconsin Carbone Cancer Center

1:20 – 1:50 p.m.

Identification and Management of Immune-Related Adverse Events in the Emergency Setting
Ronny Mario Otero MD, FAAEM - University of Michigan

1:50 – 1:55 p.m.

Posttest Questions by the Society for Immunotherapy of Cancer

1:55 – 2 p.m.

Take-Home Points for Part B and Closing Remarks


The 2017 Advances in Cancer Immunotherapy™ series is supported in part by independent medical educational grants
from Aduro Biotech, Inc., Amgen, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb, Merck & Co., Inc. and Prometheus Laboratories Inc.


#SITC #Patient #PatientAdvocate #Intermediate #CME #Clinician #PrimaryCarePhysician #Industry #Foundational #CNE #AdvancesinCancerImmunotherapyACI #Introductory #Oncologist #CPE #AlliedHealth #2017 #Nurse #Pharmacist #Webinar